Fibrous dysplasia therapy(GondolaBio)

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameFibrous dysplasia therapy(GondolaBio)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFibrous Dysplasia of Bone
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGondolaBio
China Registration ClassN/A

Develop Information

Active CompaniesGondolaBio
Inactive CompaniesN/A
Active IndicationsFibrous Dysplasia of Bone
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A